Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

Similar documents
The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management. Elham Khalaf Adeli

Transfusion & Non-transfusion Approaches to Bleeding

General Principles of. Hemostasis. Kristine Krafts, M.D.

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

Coagulation in perspective: Blood management. Objectives

Coagulation Mechanisms Dr. Nervana Bayoumy

Introduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO

Blood 101. Dr. Karen L. Dallas. Medical Director, Hematopathology & Transfusion Medicine Providence Health Care

Applying ROTEM to the Management of Bleeding in Trauma

Primary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system

Using TEG in the ED, OR, and ICU. Don H. Van Boerum, MD, FACS

Emergency and Perioperative Hemostasis Testing: Which Assays Provide Helpful Information. Wayne Chandler, MD Laboratory Medicine Seattle Children s

Disclosures. I have received research funding from: I have received consulting fees/honoraria from: Novo Nordisk CSL-Behring Boehringer Ingelheim

Coagulopathy Case-2. Andy Nguyen, M.D. 2009

Blood Product Utilization

General News. Product Notes. Instrument Notice HELENA SALES FORCE TO: FROM: SUBJECT: HELENA POINT OF CARE ROUND-UP/US DOMESTIC DATE: 9/1/2009

Platelet Factor IV- Heparin Antibodies. Presenter: Michael J. Warhol, M.D.

Factor Concentrates. More is better? Alexander Duncan MD Emory Medical Labs

Postpartum Haemorrhage make sure you give enough fibrinogen!

Coagulation Cascade. TF-VIIa. Tissue Factor + VII. XIIa. Prothrombin. XIa. IXa. VIIIa. Thrombin. XL- Fibrin. XIII Monomer. Fibrinogen.

Recombinant Factor VII vs Cryoprecipitate. Dr. M. Truter Moderator: Prof. Pretorius

General News. Product Notes

ROTEM Basic Interpretation Guide

Role of fibrinogen concentrate in coagulation management in complex cardio-vascular surgery

Dr. Susan Louw Haematopathologist NHLS / WITS / SASTH

Evaluation of Complex Coagulation Cases: Case-Based Illustrations of Important Issues

LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY

Laboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016

Alternative Haemostatic Agents in the Management of Obstetric Haemorrhage

Linking in silico and in vitro experiments to identify and evaluate a biomarker for enoxaparin activity

Optimising bleeding management: One hospital s experience DR DANIEL FAULKE

Princess Alexandra Hospital Emergency Department. Clinical Procedure. 1 Introduction

Strategies for transfusion therapy and monitoring

New Insights into the Diagnosis & Management of Venous Thromboembolism (VTE) Michael Miller, M.D.

These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.

Clinical Procedure. ROTEM Trauma, Resuscitation. Princess Alexandra Hospital Emergency Department. 1 Introduction

ANEMIA. Oral iron. IV iron gluconate (order set #233)

Massive Haemorrhage J Davies B Ferguson

Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012

Major Burns Debridement Case

Massive Haemorrhage P Donnelly B Ferguson

Use of ROTEM from the Laboratory Perspective. A/Prof David Roxby SA Pathology

CHANGE IN PLATELET USAGE

ROTEM/TEG. Circulation in trauma: From roadside to bedside. A/Prof David Roxby SA Pathology Transfusion Service South Australia

Background, Development and Clinical Use of rfviia. Slovenian Hematology Society April 17, 2015

Hematology Emergencies: Problems with Platelets

Medical Staff, House Staff, Patient Care Centers, Outpatient Clinics and UC Med Labs Clients

Sign up to receive ATOTW weekly -

The Next Big Thing. Dr Anne Weaver Consultant in Emergency Medicine & Pre-hospital Care Clinical Director for Trauma Royal London Hospital

Sonoclot Analyzer User Guide

Coagulation and postpartum haemorrhage. Peter Collins Cardiff

Basic coagulation applications and case studies

Marcia L. Zucker, Ph.D. ZIVD LLC

Secure national supply - the Australian experience

Manejo de la transfusión de plaquetas. Ileana López-Plaza, MD

REVIEW OF TRANEXAMIC ACID IN TRAUMA

Management of Bleeding in the Anticoagulated Patient Short Snappers CSIM 2015 Elizabeth Zed, MD, FRCPC October 17, 2015

Local vasoconstriction. is due to local spasm of the smooth muscle (symp. reflex) can be maintained by platelet vasoconstrictors

New factor concentrates on the way to the market

Coagulation: The Ins and Outs. Sheila K. Coffman BSMT (ASCP)

Category Storage Shelf Life Additional Criteria

BLOOD COAGULATION. 1. The initial phase of the process is vascular constriction. This limits the flow of blood to the area of injury.

Adv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file:

Acute Traumatic Coagulopathy

Use of Thromboelastography in the Management of the Trauma Patient Rio Grande Trauma Conference

Antithrombosis Management for Pediatric VAD and Beyond

Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems.

Emerging Use Of Rotational Thromboelastometry (ROTEM) in Trauma Resuscitation. Ashley Millham, CD, BSC CCPA

THE MICHELANGELO OASIS 5 PROGRAM. MichelAngelo : The Creation of Man (Fragment of the Sistine Chapel ceiling- Detail) ( )

Alberta Health Services - Edmonton Zone Massive Hemorrhage Protocol

Significant Improvement In The Management Of Major Obstetric Haemorrhage With A Rotem Guided Algorithm Using Fibrinogen Concentrate

What Can We Learn from Animal Models of Coagulopathy and Bleeding (about plasma transfusion)?

Cryoprecipitate audit within six centres in New Zealand.

ROTEM delta. Targeted therapy stops the bleeding. Easy and safe handling Fast therapeutic decisions Advanced diagnostic safety

Home truths... the clinical use of components in the UK. Jonathan Wallis. Platelets, FFP, Cryoprecipitate

Red Cell Transfusion LESSONS FROM TRAUMA

New Anticoagulants Linda Liu, M.D.

PROPHYLAXIS IN THE ORTHOPEDIC PATIENT: Martin H. Ellis MD Hematology Institute and Blood Bank Meir Medical Center Kfar Saba

Special Coagulation - APC Resistance. DiaPharma Group, Inc. Customer Service: Technical Support:

UMass Memorial Medical Center Worcester, MA

Rheological and biochemical analyses on blood coagulation ~ Discovery of a new pathway under stagnant flow conditions ~

TEG: The ABCs of Implementing Thromboelastography in a Trauma Center

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Marcia L. Zucker, Ph.D. ZIVD LLC

Common Inherited Bleeding Disorders

Coagulation Laboratory: Methods, Standards & Cost Effective Testing Part 1

ROTEM and Human Fibrinogen Concentrate Use in Pediatric Cardiac Surgery

Case 1. Case 1. Case 2. Case 2. Review of Bleeding Disorders Case 1

Session 1 Topics. Vascular Phase of Hemostasis. Coagulation Pathway. Action of Unfractionated Heparin. Laboratory Monitoring of Anticoagulant Therapy

ICU. Recovery. Plus Ultrasound-guided mechanical ventilation, F. Mojoli & S. Mongodi MANAGEMENT & PRACTICE

Transfus Med Hemother 2009;36:

Reverse the New Anticoagulants? Mitchell J Daley, PharmD, BCPS

Blood transfusion in special situations and poly-trauma. Dr Marina Karakantza Consultant Haematologist in Transfusion Medicine, LTHT

REGIONAL AUDIT OF PLASMA PRODUCTS 2016

2012, Scharbert Gisela

The New and Improved (?) Activated Factor VII Molecules

Marcia L. Zucker, Ph.D. ZIVD LLC

Managing the Risks Associated with Anticoagulant Therapy. Steve McGlynn Specialist Principal Pharmacist (Cardiology) NHS Greater Glasgow and Clyde

Lina Al-Lawama. Rama Al-Ashqar. Malik Al-Zohlof

A MANUFACTURING PROCESS TO OBTAIN A HIGHLY-PURIFIED TRIPLE-SECURED FIBRINOGEN PRODUCT

Transcription:

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm Summer Syed (local PI) Keyvan Karkouti Deputy Anesthesiologist-in-Chief, Toronto General Hospital, University Health Network Associate Professor; Department of Anesthesia and Pain Management, University of Toronto Institute of Health Policy, Management and

Transfusions at TGH 50 40 30 20 RBC FFP Platelet 4 U Tx 10 0 2012 2013

Transfusions at TGH 50 Highest in Ontario 40 30 20 RBC FFP Platelet 4 U Tx 10 0 2012 2013

Transfusions at TGH 50 Highest in Ontario 40 30 20 10 One of the Highest in Ontario RBC FFP Platelet 4 U Tx 0 2012 2013

Cardiac surgery with cardiopulmonary bypass impairs coagulation

Coagulation X TF VIIa Xa TF-Bearing Cell Va II IIa VIII/vWF V XI VIIIa Va XIa IXa TF VIIa XIa X IX II Platelet Fibrinogen IXa VIIIa Xa Va Activated Platelet IIa Fibrin Monomers X Xa II IIa III X XIII a Fibrin Matrix

Coagulation Clot

Coagulation Clot Thrombin

Coagulation Clot Thrombin

Coagulation Clot Thrombin Fibrinogen

Coagulation Clot Thrombin Fibrinogen Platelets

Coagulation Fibrinolysis Clot Thrombin Fibrinogen Platelets

Conventional coagulation tests are not very informative

Coagulation Fibrinolysis Conventional Clot coagulation tests are not very informative x Thrombin Fibrinogen Platelets

Coagulation Fibrinolysis Conventional Clot coagulation tests are not very informative x? Thrombin Fibrinogen Platelets

Coagulation Fibrinolysis Conventional Clot coagulation tests are not very informative x Thrombin Fibrinogen? x Platelets

Coagulation x Fibrinolysis Conventional Clot coagulation tests are not very informative x Thrombin Fibrinogen? x Platelets

Coagulation x Fibrinolysis Conventional Clot coagulation tests are not very informative x Thrombin Fibrinogen? x Platelets

We do not know when to initiate treatment

ROTEM

Normal clotting

Low Platelet Count or Function

Low Fibrinogen

Hyperfibrinolysis

Plateletworks

Plateletworks Uses a standard cell counter Tube 1: EDTA CBC Tube 2: Activators (e.g., collagen, ADP) Shake, then wait 4 minutes Functioning platelets clump No longer counted Therefore measuring non-functioning platelets Calculate functional platelet count: Functional platelet count = (# plt tube 1 # plt tube 2) Functional platelet % = (# plt tube 1 # plt tube 2) / (# plt tube 1)

We do not know when to initiate treatment Patient is oozy!

Institute an POC-based Algorithm Non-selective All CVS patients Enforcement All transfusions audited Multidisciplinary Anesthesia, Surgery, Perfusion, Blood bank, Hematology, Nursing

Transfusion Outcomes Pre-program (2012; n = 1303) Post-program (2013; n = 632) P-value Relative Risk Reduction RBC % 52% 40% < 0.0001 0.79 (0.72 0.87) Platelets % 34% 19% < 0.0001 0.56 (0.48 0.66) Plasma % 34% 13% < 0.0001 0.37 (0.30 0.45)

Other Clinical Outcomes Pre-program (2012; n = 1303) Post-program (2013; n = 632) P-value Relative Risk Reduction Re-exploration 6.5% 2.9% 0.001 0.48 (0.30 0.79) Massive bleeding (> 4 units RBC) Refractory bleeding (rfviia use) 20% 11% < 0.0001 0.51 (0.40 0.64) 3.4% 1.1% 0.002 0.28 (0.12 0.60) Acute kidney injury 6.1% 3.3% 0.008 0.48 (0.30 0.77)

Transfusions at TGH 50 Highest in Ontario 40 30 20 10 One of the Highest in Ontario RBC FFP Platelet 4 U Tx 0 2012 2013

Transfusions at TGH One of the Lowest in Ontario 50 40 30 20 RBC FFP Platelet 4 U Tx 10 0 2012 2013

Program Operating Expenses Item Description Unit Cost Total (per year) Labour Disposables (Reagents and Supplies) 1.2 FTE (9 5 coverage; after-hours testing to be provided by anesthesia) POCT Staff time (1 hour per week) ROTEM 2000 tests per year (1500 for cardiac; 500 for other primarily lung and liver transplant) PlateletWorks 2000 tests per year (1500 for cardiac; 500 for other primarily lung and liver transplant) Quality Control and Proficiency Testing Service Contracts $150,000 $150,000 $28 $56,000 $28 $56,000 Cost per year $13,000 Absorbed Rotem and Plateletworks service and preventative maintenance agreements $7,000 Total operating costs per year $269,000

Annual Savings in Direct Transfusion Costs Product Number saved (compared to 2012) Cost per unit* Total costs RBC (units) 1370 $840 $1,150,000 Platelet (doses) 400 $600 $240,000 Plasma (units) 1543 $80 $123,000 rfviia (doses) 30 $5000 $150,000 Total ~ 1,700,000 * Costs: CBS production costs x 2 (activity based costing estimated to be 3-5 times production costs) Not including cost-savings due to reduced complications

Blood Conservation in Cardiac Surgery Using a Novel Transfusion Algorithm Based on Point-of-Care Testing: A Stepped-Wedge Cluster Randomized Controlled Trial Does an integrated blood transfusion algorithm that employs POC coagulation tests applied across a network of hospitals reduce blood transfusions and associated adverse outcomes in cardiac surgery?

Randomization Schedule (10 hospitals) (Stepped wedge cluster randomization)

Details 11 hospitals POC algorithm will become standard-of-care Waive individual patient consent ~7000 patients will be operated on during study, ~ 4000 during intervention phase Powered to detect an absolute 8% reduction in RBC transfusion rate before and after intervention Greater reductions expected for other blood products May also detect differences in other clinical outcomes > 80% power to detect a 50% reduction in AKI

Current Status CIHR funded Multidisciplinary team at each hospital TEM and Helena will provide machines and disposables REB submission at UHN completed, at other sites in process Study group meeting in May Randomization in July/August Anticipated accrual September 2014 March 2015 Future: TBD at each site